Home / Posts Tagged "Mirum’s oral drug to become the first U.S. approved Alagille syndrome therapy"

On Wednesday, Mirum Pharmaceuticals Inc (MIRM.O) said its drug became the first U.S. approved therapy for treating itching in patients with a rare liver disorder called Alagille syndrome (ALGS). Chief Executive Officer Chris Peetz said "(Itching) is really devastating for children and families dealing with this disease